Last Updated: 15 Oct 2024
Executive Summary
Alignment Healthcare LLC (ALHC) is a provider of personalized healthcare to seniors in the United States. The company has a market capitalization of $2.19 billion and trades on the NASDAQ exchange. ALHC's latest stock price is $11.39.
Company Overview
Alignment Healthcare was founded in 2007 and is headquartered in Orange, California. The company provides a range of healthcare services to seniors, including Medicare Advantage plans, Medicare Supplement plans, and prescription drug plans. ALHC also offers a variety of value-added services, such as care management, disease management, and wellness programs.
Fundamental Analysis
ALHC's financial performance has been mixed in recent years. The company's revenue has grown steadily, but its profitability has declined. In 2023, ALHC reported a net loss of $104.5 million on revenue of $2.23 billion.
ALHC's financial ratios are also mixed. The company's price-to-sales ratio is 0.98, which is below the industry average. However, ALHC's price-to-book ratio is 17.61, which is above the industry average.
Technical Analysis
ALHC's stock price has been trending lower in recent months. The stock is currently trading below its 50-day and 200-day moving averages. The stock's relative strength index (RSI) is also below 50, which indicates that the stock is oversold.
Short Term Outlook
ALHC's short-term outlook is uncertain. The company's financial performance has been mixed, and its stock price has been trending lower. However, ALHC's stock is currently trading at a discount to its intrinsic value. This suggests that the stock could be a good value for investors who are willing to take on some risk.
Long Term Outlook
ALHC's long-term outlook is positive. The company is a leader in the Medicare Advantage market, and it is well-positioned to benefit from the aging population in the United States. ALHC's stock is also trading at a discount to its intrinsic value, which suggests that the stock could be a good investment for long-term investors.
Analyst Recommendations
The majority of analysts who cover ALHC have a buy rating on the stock. The average analyst target price for ALHC is $10.35.
